BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 1,751.00
-289.00 (-14.17%)
At close: Oct 23, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 8.52 billion as of October 23, 2026. It is the 43,744th most valuable company in the world and the 2,656th biggest in South Korea. Its market cap has decreased by 63.37% in one year.
Market Cap
8.52B
Enterprise Value
15.22B
Revenue
25.62B
Global Rank
Country Rank
#2,656 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 8.52B, a decrease of -93.96%. That is a compound annual growth rate of -53.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 8.52B | -62.98% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
| Mar 2, 2023 | 141.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 308.32B |
| DreamCIS | 100.62B |
| HLB bioStep | 99.10B |
| P&K Skin Research Center | 47.91B |
| Kolmar BioTech | 34.92B |
| DT&CRO CO. | 29.60B |
| SLS BIO | 26.89B |
| C&R Research | 25.69B |